The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania

References

• Ader M, Kim SP, Catalano KJ, Ionut V, Hucking K, Richey JM, et al. Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease: a placebo-controlled study of olanzapine and risperidone in dogs. Diabetes 2005; 54: 862–871
   PubMed Web of Science ®Google Scholar
• Adler LW. Mixed bipolar disorder responsive to lithium and clonazepam. J Clin Psychiatry 1986; 47: 49–50
   PubMedGoogle Scholar
• Allen MH, Hirschfeld RM, Wozniak PJ, Baker JD, Bowden CL. Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania. Am J Psychiatry 2006; 163: 272–275
   PubMed Web of Science ®Google Scholar
• Amann B, Sterr A, Mergl R, Dittmann S, Seemuller F, Dobmeier M, et al. Zotepine loading in acute and severely manic patients: a pilot study. Bipolar Disord 2005; 7: 471–476
   PubMed Web of Science ®Google Scholar
• Amann B, Sterr A, Vieta E, Stampfer R, Walden J, Grunze H. An exploratory open trial on safety and efficacy of the anticonvulsant retigabine in acute manic patients. J Clin Psychopharmacol 2006; 26: 534–536
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders. 4th revised ed. Washington, DC: American Psychiatric Press.
   Google Scholar
• Anand A, Bukhari L, Jennings SA, Lee C, Kamat M, Shekhar A, et al. A preliminary open-label study of zonisamide treatment for bipolar depression in 10 patients. J Clin Psychiatry 2005; 66: 195–198
   PubMedGoogle Scholar
• Anderson J. On variability of effects for a metaanalysis of rheumatoid arthritis radiographic progression. J Rheumatol 2000; 27: 540–542
   PubMedGoogle Scholar
• Angst J. Epidemiologie du spectre bipolaire. Encephale 1995; 21: 37–42
   PubMed Web of Science ®Google Scholar
• Angst J. Bipolar disorder–a seriously underestimated health burden. Eur Arch Psychiatry Clin Neurosci 2004; 254: 59–60
   PubMedGoogle Scholar
• Angst J. Do many patients with depression suffer from bipolar disorder?. Can J Psychiatry 2006; 51: 3–5
   PubMedGoogle Scholar
• Antonacci DJ, Swartz CM. Clozapine treatment of euphoric mania. Ann Clin Psychiatry 1995; 7: 203–206
   PubMedGoogle Scholar
• Arnold LM, McElroy SL, Keck PE. The role of gender in mixed mania. Compr Psychiatry 2000; 41: 83–87
   PubMed Web of Science ®Google Scholar
• Baker RW, Tohen M, Fawcett J, Risser RC, Schuh LM, Brown E, et al. Acute dysphoric mania: treatment response to olanzapine versus placebo. J Clin Psychopharmacol 2003; 23: 132–137
   PubMed Web of Science ®Google Scholar
• Baker RW, Brown E, Akiskal HS, Calabrese JR, Ketter TA, Schuh LM, et al. Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania. Br J Psychiatry 2004; 185: 472–478
   PubMed Web of Science ®Google Scholar
• Ballenger JC, Post RM. Carbamazepine in manic-depressive illness: a new treatment. Am J Psychiatry 1980; 137: 782–790
   PubMed Web of Science ®Google Scholar
• Bandelow B, Zohar J, Hollander E, Kasper S, Moller HJ, Zohar J, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders – first revision. World J Biol Psychiatry 2008; 9: 248–312
   PubMed Web of Science ®Google Scholar
• Barekatain M, Jahangard L, Haghighi M, Ranjkesh F. Bifrontal versus bitemporal electroconvulsive therapy in severe manic patients. J ECT 2008; 24: 199–202
   PubMedGoogle Scholar
• Basco MR, Rush AJ. Cognitive behavioral therapy for bipolar disorder. Guildford Press, New York 1996
   Google Scholar
• Baumann P, Hiemke C, Ulrich S, Eckermann G, Gaertner I, Kuss HJ, et al. The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry. Pharmacopsychiatry 2004; 37: 243–265
   PubMed Web of Science ®Google Scholar
• Bech P, Gex-Fabry M, Aubry JM, Favre S, Bertschy G. Olanzapine plasma level in relation to antimanic effect in the acute therapy of manic states. Nord J Psychiatry 2006; 60: 181–182
   PubMed Web of Science ®Google Scholar
• Benabarre A, Vieta E, Colom F, Martinez A, Reinares M, Corbella B. Treatment of mixed mania with risperidone and mood stabilizers. Can J Psychiatry 2001; 46: 866–867
   PubMed Web of Science ®Google Scholar
• Benazzi F. Bipolar II disorder : epidemiology, diagnosis and management. CNS Drugs 2007; 21: 727–740
   PubMed Web of Science ®Google Scholar
• Berk M, Ichim L, Brook S. Olanzapine compared to lithium in mania: A double-blind randomized controlled trial. Int Clin Psychopharmacol 1999; 14: 339–343
   PubMed Web of Science ®Google Scholar
• Black DW, Winokur G, Nasrallah A. Treatment of mania: a naturalistic study of electroconvulsive therapy versus lithium in 438 patients. J Clin Psychiatry 1987; 48: 132–139
   PubMed Web of Science ®Google Scholar
• Bottai T, Hue B, Hillaire-Buys D, Barbe A, Alric R, Pouget R, et al. Clonazepam in acute mania: time-blind evaluation of clinical response and concentrations in plasma. J Affect Disord 1995; 36: 21–27
   PubMedGoogle Scholar
• Bowden C, Gogus A, Grunze H, Haggstrom L, Rybakowski J, Vieta E. A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode. Int Clin Psychopharmacol 2008; 23: 254–262
   PubMed Web of Science ®Google Scholar
• Bowden, CL, Singh, V. 2005. Valproate in bipolar disorder: 2000 onwards. Acta Psychiatr Scand Suppl. 13–20.
   PubMedGoogle Scholar
• Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, et al. Efficacy of divalproex vs. lithium and placebo in the treatment of mania. The Depakote Mania Study Group. J Am Med Assoc 1994; 271: 918–924
   PubMed Web of Science ®Google Scholar
• Bowden CL, Grunze H, Mullen J, Brecher M, Paulsson B, Jones M, et al. A Randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. J Clin Psychiatry 2005; 66: 111–121
   PubMed Web of Science ®Google Scholar
• Bowden CL, Swann AC, Calabrese JR, Rubenfaer LM, Wozniak PJ, Collins MA, et al. A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania. J Clin Psychiatry 2006; 67: 1501–1510
   PubMed Web of Science ®Google Scholar
• Bradwejn J, Shriqui C, Koszycki D, Meterissian G. Double-blind comparison of the effects of clonazepam and lorazepam in acute mania. J Clin Psychopharmacol 1990; 10: 403–408
   PubMed Web of Science ®Google Scholar
• Brown D, Silverstone T, Cookson J. Carbamazepine compared to haloperidol in acute mania. Int Clin Psychopharmacol 1989; 4: 229–238
   PubMed Web of Science ®Google Scholar
• Brunet G, Cerlich B, Robert P, Dumas S, Souetre E, Darcourt G. Open trial of a calcium antagonist, nimodipine, in acute mania. Clin Neuropharmacol 1990; 13: 224–228
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Kimmel SE, Woyshville MJ, Rapport DJ, Faust CJ, Thompson PA, et al. Clozapine for treatment-refractory mania. Am J Psychiatry 1996; 153: 759–764
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Keck PE, Jr, Macfadden W, Minkwitz M, Ketter TA, Weisler RH, et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 2005; 162: 1351–1360
   PubMed Web of Science ®Google Scholar
• Calabrese, JR, Cohen, M, Zhao, J, Panagides, J. 2008. Efficacy and safety of asenapine as adjunctive treatment for acute mania associated with bipolar disorder. Proceedings of the 161th APA Conference, Washington, DC, May 3–8.
   Google Scholar
• Chou JC, Czobor P, Charles O, Tuma I, Winsberg B, Allen MH, et al. Acute mania: haloperidol dose and augmentation with lithium or lorazepam. J Clin Psychopharmacol 1999; 19: 500–505
   PubMed Web of Science ®Google Scholar
• Chouinard G. Clonazepam in acute and maintenance treatment of bipolar affective disorder. J Clin Psychiatry (Suppl) 1987; 48: 29–37
   PubMed Web of Science ®Google Scholar
• Chouinard G, Young SN, Annable L. Antimanic effect of clonazepam. Biol Psychiatry 1983; 18: 451–466
   PubMed Web of Science ®Google Scholar
• Chouinard G, Annable L, Turnier L, Holobow N, Szkrumelak N. A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms. Can J Psychiatry 1993; 38(Suppl 4)114–121
   PubMedGoogle Scholar
• Cipriani A, Rendell JM, Geddes JR. Haloperidol alone or in combination for acute mania. Cochrane Database Syst Rev 2006; 3: CD004362
   PubMedGoogle Scholar
• Clark HM, Berk M, Brook S. A randomized controlled single blind study of the efficacy of clonazepam and lithium in the treatment of acute mania. Hum Psychopharmacol 1997; 12: 325–328
   Web of Science ®Google Scholar
• Cookson JC, Silverstone T, Wells B. A double-blind controlled study of pimozide versus chlorpromazine in mania. Psychopharmacol Bull 1980; 16: 38–41
   PubMedGoogle Scholar
• Cutler AJ, Datto C, Nordenhem A, Dettore B, Acevedo L, Darko D. Effectiveness of extended release formulation of quetiapine as montherapy for the treatment of acute bipolar mania (trial D144CC00004). Int J Neuropsychopharmacol 2008; 11(Suppl 1)184
   Google Scholar
• De Marcos FA, Ghizoni E, Kobayashi E, Li LM, Cendes F. Cerebellar volume and long-term use of phenytoin. Seizure 2003; 12: 312–315
   PubMed Web of Science ®Google Scholar
• DelBello MP, Schwiers ML, Rosenberg HL, Strakowski SM. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry 2002; 41: 1216–1223
   PubMed Web of Science ®Google Scholar
• DelBello MP, Kowatch RA, Adler CM, Stanford KE, Welge JA, Barzman DH, et al. A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. J Am Acad Child Adolesc Psychiatry 2006; 45: 305–313
   PubMed Web of Science ®Google Scholar
• Desarkar P, Das B, Sinha VK. Adjuvant levetiracetam in adolescent mania. J Clin Psychopharmacol 2007; 27: 215–216
   PubMedGoogle Scholar
• Dose M, Emrich HM. Acute mania: Practical therapeutic guidelines. CNS Drugs 1995; 3: 427–435
   Google Scholar
• Dubovsky SL, Franks RD, Allen S, Murphy J. Calcium antagonists in mania: a double-blind study of verapamil. Psychiatry Res 1986; 18: 309–320
   PubMed Web of Science ®Google Scholar
• Edwards R, Stephenson U, Flewett T. Clonazepam in acute mania: a double blind trial. Aust NZ J Psychiatry 1991; 25: 238–242
   PubMed Web of Science ®Google Scholar
• Elphick M. An open clinical trial of carbamazepine in treatment-resistant bipolar and schizo-affective psychotics. Br J Psychiatry 1985; 147: 198–200
   PubMed Web of Science ®Google Scholar
• Emrich HM, Dose M, von Zerssen D. The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders. J Affect Disord 1985; 8: 243–250
   PubMed Web of Science ®Google Scholar
• Emrich HM, von Zerssen D, Kissling W, Möller H-J, Windorfer A. Effect of sodium valproate on mania. The GABA-hypothesis of affective disorders. Arch Psychiatr Nervenkr 1980; 229: 1–16
   PubMedGoogle Scholar
• Endicott J, Spitzer RL. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 1978; 35: 837–844
   PubMed Web of Science ®Google Scholar
• Fountoulakis KN, Vieta E, Sanchez-Moreno J, Kaprinis SG, Goikolea JM, Kaprinis GS. Treatment guidelines for bipolar disorder: a critical review. J Affect Disord 2005; 86: 1–10
   PubMed Web of Science ®Google Scholar
• Franciosi LP, Kasper S, Garber AJ, Johnson DL, Krauss RM, Marder SR, et al. Advancing the treatment of people with mental illness: a call to action in the management of metabolic issues. J Clin Psychiatry 2005; 66: 790–798
   PubMedGoogle Scholar
• Freeman TW, Clothier JL, Pazzaglia P, Lesem MD, Swann AC. A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry 1992; 149: 108–111
   PubMed Web of Science ®Google Scholar
• Frye MA, Ketter TA, Altshuler LL, Denicoff K, Dunn RT, Kimbrell TA, et al. Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics. J Affect Disord 1998; 48: 91–104
   PubMed Web of Science ®Google Scholar
• Gajwani P, Forsthoff A, Muzina D, Amann B, Gao K, Elhaj O, et al. Antiepileptic drugs in mood-disordered patients. Epilepsia 2005; 46(Suppl 4)38–44
   PubMedGoogle Scholar
• Garfinkel PE, Stancer HC, Persad E. A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania. J Affect Disord 1980; 2: 279–288
   PubMed Web of Science ®Google Scholar
• Geddes J, Freemantle N, Harrison P, Bebbington P. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. Br Med J 2000; 321: 1371–1376
   PubMed Web of Science ®Google Scholar
• Ghaemi SN, Hsu DJ, Thase ME, Wisniewski SR, Nierenberg AA, Miyahara S, et al. Pharmacological treatment patterns at study entry for the first 500 STEP-BD participants. Psychiatr Serv 2006; 57: 660–665
   PubMed Web of Science ®Google Scholar
• Goldberg JF, Burdick KE. Levetiracetam for acute mania. Am J Psychiatry 2002; 159: 148
   PubMed Web of Science ®Google Scholar
• Goldberg JF, Harrow M. Which unipolar depressives are really bipolar?. APA Annual Meeting Abstracts 1998; 151: 29
   Google Scholar
• Goldberg JF, Harrow M, Whiteside JE. Risk for bipolar illness in patients initially hospitalized for unipolar depression. Am J Psychiatry 2001; 158: 1265–1270
   PubMed Web of Science ®Google Scholar
• Goldsmith DR, Wagstaff AJ, Ibbotson T, Perry CM. Lamotrigine: a review of its use in bipolar disorder. Drugs 2003; 63: 2029–2050
   PubMed Web of Science ®Google Scholar
• Goncalves N, Stoll K-D. Carbamazepin bei manischen Syndromen. Eine kontrollierte Doppelblind-Studie. Nervenarzt 1985; 56: 43–47
   PubMed Web of Science ®Google Scholar
• Goodwin FK, Jamison KR. Manic-depressive illness2nd ed. Oxford University Press, New York 2007
   Google Scholar
• Goodwin GM. Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder. Br J Psychiatry 1994; 164: 149–152
   PubMed Web of Science ®Google Scholar
• Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, Nolen WA, Vieta E, Wittchen HU. ECNP consensus meeting. Bipolar Depression. Nice, March 2007. Eur Neuropsychopharmacol 2008; 18: 535–549
   PubMed Web of Science ®Google Scholar
• Gouliaev G, Licht RW, Vestergaard P, Merinder L, Lund H, Bjerre L. Treatment of manic episodes: zuclopenthixol and clonazepam versus lithium and clonazepam. Acta Psychiatr Scand 1996; 93: 119–124
   PubMedGoogle Scholar
• Green AI, Tohen M, Patel JK, Banov M, DuRand C, Berman I, et al. Clozapine in the treatment of refractory psychotic mania. Am J Psychiatry 2000; 157: 982–986
   PubMed Web of Science ®Google Scholar
• Greenberg WM, Citrome L. Ziprasidone for schizophrenia and bipolar disorder: a review of the clinical trials. CNS Drug Rev 2007; 13: 137–177
   PubMedGoogle Scholar
• Grunze H. Lithium in the acute treatment of bipolar disorders-a stocktaking. Eur Arch Psychiatry Clin Neurosci 2003; 253: 115–119
   PubMedGoogle Scholar
• Grunze H. Carbamazepine, Other anticonvulsants and augmenting agents. Bipolar psychopharmacotherapy: Caring for the patient, HS Akiskal, M Tohen. John Wiley & Sons, London 2006; 63–84
   Google Scholar
• Grunze H, Scharfetter J. Elektrokonvulsionstherapie der manischen Episode im Rahmen einer bipolaren affektiven Störung. Klinische und wissenschaftliche Aspekte der Elektrokonvulsionstherapie, T Baghai, R Frey, S Kasper, H–J Möller. Springer, Wien 2004
   Google Scholar
• Grunze H, Walden J. Relevance of new and newly rediscovered anticonvulsants for atypical forms of bipolar disorder. J Affect Disord 2002; 72(Suppl 1)15–21
   PubMedGoogle Scholar
• Grunze H, Erfurth A, Marcuse A, Amann B, Normann C, Walden J. Lack of antimanic efficacy of the GABA transporter 1 inhibitor tiagabine. Eur Neuropsychopharmacol 1998; 8(Suppl 2)195
   PubMedGoogle Scholar
• Grunze H, Erfurth A, Amann B, Giupponi G, Kammerer C, Walden J. Intravenous valproate loading in acutely manic and depressed bipolar I patients. J Clin Psychopharmacol 1999; 19: 303–309
   PubMed Web of Science ®Google Scholar
• Grunze H, Kasper S, Goodwin G, Bowden CL, Baldwin D, Licht RW, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders. Part I: Treatment of Bipolar Depression. World J Biol Psychiatry 2002; 3: 115–124
   PubMedGoogle Scholar
• Grunze H, Kasper S, Goodwin G, Bowden CL, Baldwin D, Licht RW, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders. Part II: Treatment of Mania. World J Biol Psychiatry 2003a; 4: 5–13
   PubMed Web of Science ®Google Scholar
• Grunze H, Langosch J, Born C, Schaub G, Walden J. Levetiracetam in the treatment of acute mania: an open add-on study with an on-off-on design. J Clin Psychiatry 2003b; 64: 781–784
   PubMed Web of Science ®Google Scholar
• Grunze H, Kasper S, Goodwin G, Bowden CL, Möller H-J, Task Force on Treatment Guidelines for Bipolar Disorders WFSBP. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders. Part III: Maintenance treatment. World J Biol Psychiatry 2004; 5: 120–135
   PubMed Web of Science ®Google Scholar
• Gutierrez MJ, Scott J. Psychological treatment for bipolar disorders–a review of randomised controlled trials. Eur Arch Psychiatry Clin Neurosci 2004; 254: 92–98
   PubMed Web of Science ®Google Scholar
• Hah M, Hallmayer JF. Tamoxifen and mania: a double-blind, placebo-controlled trial. Curr Psychiatry Rep 2008; 10: 200–201
   PubMedGoogle Scholar
• Hakkaart-van RL, Hoeijenbos MB, Regeer EJ, ten HM, Nolen WA, Veraart CP, et al. The societal costs and quality of life of patients suffering from bipolar disorder in the Netherlands. Acta Psychiatr Scand 2004; 110: 383–392
   PubMedGoogle Scholar
• Hamra BJ, Nasrallah HA, Clancy J, Finn R. Psychiatric diagnosis and risk for tardive dyskinesia. Arch Gen Psychiatry 1983; 40: 346–347
   PubMed Web of Science ®Google Scholar
• Harada T, Otsuki S. Antimanic effect of zotepine. Clin Ther 1986; 8: 406–414
   PubMed Web of Science ®Google Scholar
• Hayden EP, Nurnberger JI. Molecular genetics of bipolar disorder. Genes Brain Behav 2006; 5: 85–95
   PubMed Web of Science ®Google Scholar
• Heres S, Davis J, Maino K, Jetzinger E, Kissling W, Leucht S. Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics. Am J Psychiatry 2006; 163: 185–194
   PubMed Web of Science ®Google Scholar
• Himmelhoch JM, Garfinkel ME. Sources of lithium resistance in mixed mania. Psychopharmacol Bull 1986; 22: 613–620
   PubMed Web of Science ®Google Scholar
• Hiremani RM, Thirthalli J, Tharayil BS, Gangadhar BN. Double-blind randomized controlled study comparing short-term efficacy of bifrontal and bitemporal electroconvulsive therapy in acute mania. Bipolar Disord 2008; 10: 701–707
   PubMed Web of Science ®Google Scholar
• Hirschfeld R, Panagides J, Alphs L, Cohen M, Lancaster S, Macek T. Asenapine in acute mania: a randomized, double-blind, placebo- and olanzapine-controlled trial (ARES 7501005). Bipolar Disord 2007; 9(Suppl 1)53
   PubMedGoogle Scholar
• Hirschfeld RM, Kasper S. A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder. Int J Neuropsychopharmacol 2004; 7: 507–522
   PubMed Web of Science ®Google Scholar
• Hirschfeld RM, Allen MH, McEvoy JP, Keck PE, Jr, Russell JM. Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients. J Clin Psychiatry 1999; 60: 815–818
   PubMed Web of Science ®Google Scholar
• Hirschfeld RM, Baker JD, Wozniak P, Tracy K, Sommerville KW. The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder. J Clin Psychiatry 2003; 64: 841–846
   PubMed Web of Science ®Google Scholar
• Hirschfeld RM, Keck PE, Jr, Kramer M, Karcher K, Canuso C, Eerdekens M, et al. Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial. Am J Psychiatry 2004; 161: 1057–1065
   PubMed Web of Science ®Google Scholar
• Ichim L, Berk M, Brook S. Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial. Ann Clin Psychiatry 2000; 12: 5–10
   PubMedGoogle Scholar
• Janicak PG, Bresnahan DB, Sharma R, Davis JM, Comaty JE, Malinick C. A comparison of thiothixene with chlorpromazine in the treatment of mania. J Clin Psychopharmacol 1988; 8: 33–37
   PubMedGoogle Scholar
• Janicak PG, Sharma R, Pandey G, Davis JM. Verapamil for the treatment of acute mania: a double-blind, placebo- controlled trial. Am J Psychiatry 1998; 155: 972–973
   PubMed Web of Science ®Google Scholar
• Johnson G, Gershon S, Burdock EI, Floyd A, Hekimian L. Comparative effects of lithium and chlorpromazine in the treatment of acute manic states. Br J Psychiatry 1971; 119: 267–276
   PubMed Web of Science ®Google Scholar
• Johnstone EC, Crow TJ, Frith CD, Owens DG. The Northwick Park “functional” psychosis study: diagnosis and treatment response. Lancet 1988; ii: 119–125
   Google Scholar
• Jon DI, Bahk WM, Yoon BH, Shin YC, Cho HS, Lee E, Ha K, Kim W, Chung SK, Seo JS, Min KJ. Revised Korean medication algorithm for bipolar disorder. World J Biol Psychiatry 2008; 10: 1–10
   Google Scholar
• Kanba S, Yagi G, Kamijima K, Suzuki T, Tajima O, Otaki J, et al. The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania. Prog Neuropsychopharmacol Biol Psychiatry 1994; 18: 707–715
   PubMed Web of Science ®Google Scholar
• Kane, JM. 1999. Tardive dyskinesia in affective disorders. J Clin Psychiatry, 60(Suppl 5):43–47, discussion 48–49.
   PubMedGoogle Scholar
• Kaptsan A, Yaroslavsky Y, Applebaum J, Belmaker RH, Grisaru N. Right prefrontal TMS versus sham treatment of mania: a controlled study. Bipolar Disord 2003; 5: 36–39
   PubMed Web of Science ®Google Scholar
• Karmacharya R, England ML, Ongur D. Delirious mania: clinical features and treatment response. J Affect Disord 2008; 109: 312–316
   PubMed Web of Science ®Google Scholar
• Kasper S, Agren H, Bourgeois ML, Cassano GB, Chengappa KN, Cookson J, et al. The BEAM panel. Clinical overview – Module 2: Recognizing bipolar disorder. Complete Medical Communications (CMC), MacclesfieldUK 2002
   Google Scholar
• Kasper S, Lowry AJ, Hodge A, Bitter I, Dossenbach M. Tardive Dyskinesia: analysis of outpatients with schizophrenia from Africa and the Middle East, Asia, Central and Eastern Europe, and Latin America. Schizophr Res 2006; 81: 139–143
   PubMed Web of Science ®Google Scholar
• Keck PE, McElroy SL, Tugrul KC, Bennett JA. Valproate oral loading in the treatment of acute mania. J Clin Psychiatry 1993; 54: 305–308
   PubMed Web of Science ®Google Scholar
• Keck PE, McElroy SL, Strakowski SM, Soutullo CA. Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia. J Clin Psychiatry 2000; 61(Suppl 4)33–38
   PubMed Web of Science ®Google Scholar
• Keck PE, Strakowski SM, Hawkins JM, Dunayevich E, Tugrul KC, Bennett JA, et al. A pilot study of rapid lithium administration in the treatment of acute mania. Bipolar Disord 2001; 3: 68–72
   PubMed Web of Science ®Google Scholar
• Keck PE, Bowden CL, Meinhold JM, Gyulai L, Prihoda TJ, Baker JD, Wozniak PJ. Relationship between serum valproate and lithium levels and efficacy and tolerability in bipolar maintenance therapy. Int J Psychiaty Clin Pract 2005; 9: 271–277
   PubMed Web of Science ®Google Scholar
• Keck PE, Calabrese JR, McQuade RD, Carson WH, Carlson BX, Rollin LM, et al. A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder. J Clin Psychiatry 2006; 67: 626–637
   PubMed Web of Science ®Google Scholar
• Keck PE, Marcus R, Tourkodimitris S, Ali M, Liebeskind A, Saha A, Ingenito G. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am J Psychiatry 2003a; 160: 1651–1658
   PubMed Web of Science ®Google Scholar
• Keck PE, Versiani M, Potkin S, West SA, Giller E, Ice K. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Am J Psychiatry 2003b; 160: 741–748
   PubMed Web of Science ®Google Scholar
• Keck PE, Versiani M, Potkin S, West SA, Giller E, Ice K. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Am J Psychiatry 2003c; 160: 741–748
   PubMed Web of Science ®Google Scholar
• Keck, PE, Sanchez, R, Marcus, R, Carson, W, Rollin, L, Iwamoto, T, Stock, E. 2004. Aripiprazole for relapse prevention in bipolar disorder in a 26-week trial. Proc APA Annu Meeting NR 796.
   Google Scholar
• Keck, PE, Sanchez, R, Torbeyns, A, Marcus, RN, McQuade, RD, Forbes, A. 2007. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, placebo- and lithium-controlled study. Program and abstracts of the 160th Annual Meeting of the American Psychiatric Association; May 19–24, 2007; San Diego, CA. New Research Poster 304.
   Google Scholar
• Kelly DL, Conley RR, Tamminga CA. Differential olanzapine plasma concentrations by sex in a fixed-dose study. Schizophr Res 1999; 40: 101–104
   PubMed Web of Science ®Google Scholar
• Kelly DL, Richardson CM, Yu Y, Conley RR. Plasma concentrations of high-dose olanzapine in a double-blind crossover study. Hum Psychopharmacol 2006; 21: 393–398
   PubMed Web of Science ®Google Scholar
• Khanna S, Vieta E, Lyons B, Grossman F, Eerdekens M, Kramer M. Risperidone in the treatment of acute mania: double-blind, placebo-controlled study. Br J Psychiatry 2005; 187: 229–234
   PubMed Web of Science ®Google Scholar
• Khazaal Y, Tapparel S, Chatton A, Rothen S, Preisig M, Zullino D. Quetiapine dosage in bipolar disorder episodes and mixed states. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 727–730
   PubMedGoogle Scholar
• Klein DF, Oak G. Importance of psychiatric diagnosis in prediction of clinical drug effects. Arch Gen Psychiatry 1967; 16: 118–126
   PubMed Web of Science ®Google Scholar
• Klein E, Bental E, Lerer B, Belmaker RH. Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses. A controlled study. Arch Gen Psychiatry 1984; 41: 165–170
   PubMed Web of Science ®Google Scholar
• Kulkarni J, Garland KA, Scaffidi A, Headey B, Anderson R, de CA, Fitzgerald P, et al. A pilot study of hormone modulation as a new treatment for mania in women with bipolar affective disorder. Psychoneuroendocrinology 2006; 31: 543–547
   PubMed Web of Science ®Google Scholar
• Kupka RW, Luckenbaugh DA, Post RM, Suppes T, Altshuler LL, Keck PE, et al. Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients. Am J Psychiatry 2005; 162: 1273–1280
   PubMed Web of Science ®Google Scholar
• Kushner SF, Khan A, Lane R, Olson WH. Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials. Bipolar Disord 2006; 8: 15–27
   PubMed Web of Science ®Google Scholar
• Kusumakar V, Yatham LN, Haslam DR, Parikh SV, Matte R, Silverstone PH, et al. Treatment of mania, mixed state, and rapid cycling. Can J Psychiatry 1997; 42(Suppl 2)79–86
   PubMedGoogle Scholar
• Kyomen HH. The use of levetiracetam to decrease mania in elderly bipolar patients. Am J Geriatr Psychiatry 2006; 14: 985
   PubMedGoogle Scholar
• Lambert PA, Venaud G. Utilisation de valpromide en therapeutique psychiatrique. L'encephale 1966; 8: 367–373
   Google Scholar
• Lenox RH, Newhouse PA, Creelman WL, Whitaker TM. Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study. J Clin Psychiatry 1992; 53: 47–52
   PubMed Web of Science ®Google Scholar
• Lerer B, Moore N, Meyendorff E, Cho SR, Gershon S. Carbamazepine versus lithium in mania: a double-blind study. J Clin Psychiatry 1987; 48: 89–93
   PubMed Web of Science ®Google Scholar
• Letmaier M, Schreinzer D, Reinfried L, Glauninger G, Thierry N, Kapitany T, et al. Typical neuroleptics vs. atypical antipsychotics in the treatment of acute mania in a natural setting. Int J Neuropsychopharmacol 2006; 9: 529–537
   PubMedGoogle Scholar
• Lexchin J, Light DW. Commercial influence and the content of medical journals. Br Med J 2006; 332: 1444–1447
   PubMed Web of Science ®Google Scholar
• Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. Br Med J 2003; 326: 1167–1170
   PubMed Web of Science ®Google Scholar
• Licht RW. Lithium in the treatment of acute mania. Lithium in neuropsychiatry – the comprehensive guide, M Bauer, P Grof, B Müller-Oerlinghausen. Informa Healthcare, London 2006; 59–72
   Google Scholar
• Licht RW, Gouliaev G, Vestergaard P, Frydenberg M. Generalisability of results from randomised drug trials. A trial on antimanic treatment. Br J Psychiatry 1997; 170: 264–267
   PubMed Web of Science ®Google Scholar
• Licht RW, Bysted M, Christensen H. ICD-10 versus DSM-IV diagnostic criteria for bipolar mania: a clinical comparison. Bipolar Disord 2001; 3(Suppl)19–20
   Google Scholar
• Licht, RW, Vestergaard, P, Kessing, LV, Larsen, JK, Thomsen, PH. 2003. Psychopharmacological treatment with lithium and antiepileptic drugs: suggested guidelines from the Danish Psychiatric Association and the Child and Adolescent Psychiatric Association in Denmark. Acta Psychiatr Scand Suppl. 1–22.
   PubMedGoogle Scholar
• Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New Engl J Med 2005; 353: 1209–1223
   PubMed Web of Science ®Google Scholar
• Lima L. Region-selective reduction of brain serotonin turnover rate and serotonin agonist- induced behavior in mice treated with clonazepam. Pharmacol Biochem Behav 1991; 39: 671–676
   PubMedGoogle Scholar
• Lin D, Mok H, Yatham LN. Polytherapy in bipolar disorder. CNS Drugs 2006; 20: 29–42
   PubMed Web of Science ®Google Scholar
• Lusznat RM, Murphy DP, Nunn CM. Carbamazepine vs. lithium in the treatment and prophylaxis of mania. Br J Psychiatry 1988; 153: 198–204
   PubMed Web of Science ®Google Scholar
• Macritchie, K, Geddes, JR, Scott, J, Haslam, D, de Lima, M, Goodwin, G. 2003. Valproate for acute mood episodes in bipolar disorder. Cochrane Database Syst Rev, CD004052.
   PubMedGoogle Scholar
• Maina G, Albert U, Bellodi L, Colombo C, Faravelli C, Monteleone P, et al. Health-related quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes. J Clin Psychiatry 2007; 68: 207–212
   PubMed Web of Science ®Google Scholar
• McCabe MS, Norris B. ECT versus chlorpromazine in mania. Biol Psychiatry 1977a; 12: 245–254
   PubMedGoogle Scholar
• McCabe MS, Norris B. ECT versus chlorpromazine in mania. Biol Psychiatry 1977b; 12: 245–254
   PubMedGoogle Scholar
• McCormack PL, Wiseman LR. Olanzapine: a review of its use in the management of bipolar I disorder. Drugs 2004; 64: 2709–2726
   PubMed Web of Science ®Google Scholar
• McElroy SL, Keck PE, Stanton SP, Tugrul KC, Bennett JA, Strakowski SM. A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. J Clin Psychiatry 1996a; 57: 142–146
   PubMed Web of Science ®Google Scholar
• McElroy SL, Keck PE, Strakowski SM. Mania, psychosis, and antipsychotics. J Clin Psychiatry 1996b; 57(Suppl 3)14–26
   PubMedGoogle Scholar
• McElroy SL, Suppes T, Keck PE, Jr, Black D, Frye MA, Altshuler LL, et al. Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial. J Clin Psychiatry 2005; 66: 617–624
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Mancini DA, Parikh S, Kennedy SH. Lithium revisited. Can J Psychiatry 2001; 46: 322–327
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Brecher M, Paulsson B, Huizar K, Mullen J. Quetiapine or haloperidol as monotherapy for bipolar mania–a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial. Eur Neuropsychopharmacol 2005; 15: 573–585
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Soczynska JK, Woldeyohannes HO, Miranda A, Konarski JZ. Aripiprazole: pharmacology and evidence in bipolar disorder. Expert Opin Pharmacother 2007; 8: 1001–1009
   PubMed Web of Science ®Google Scholar
• McIntyre R, Hirschfeld R, Alphs L, Cohen M, Macek T, Panagides J. Randomized, placebo-controlled studies of asenapine in the treatment of acute mania in bipolar I disorder (Ares 1004/1005). J Affect Disord 2008a; 107(Suppl 1)56
   Google Scholar
• McIntyre RS, Cohen M, Zhao J, Panagides J. Double-blind extension studies of asenapine in patients with bipolar mania. Proceedings of the 161st APA Conference, Washington, DC. May 2008b; 3–8: 2008
   Google Scholar
• Meehan K, Zhang F, David S, Tohen M, Janicak P, Small J, et al. A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania. J Clin Psychopharmacol 2001; 21: 389–397
   PubMed Web of Science ®Google Scholar
• Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry 2007; 64: 543–552
   PubMed Web of Science ®Google Scholar
• Mishory A, Yaroslavsky Y, Bersudsky Y, Belmaker RH. Phenytoin as an antimanic anticonvulsant: a controlled study. Am J Psychiatry 2000; 157: 463–465
   PubMed Web of Science ®Google Scholar
• Morishita S, Aoki S. A trial of clonazepam treatment for manic-depressive psychoses. Nihon Shinkei Seishin Yakurigaku Zasshi 1999; 19: 127–132
   PubMedGoogle Scholar
• Morrow J, Russell A, Guthrie E, Parsons L, Robertson I, Waddell R, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006; 77: 193–198
   PubMed Web of Science ®Google Scholar
• Morselli P, Elgie R, Cesana B. GAMIAN-Europe/BEAM survey II: cross-national analysis of unemployment, family history, treatment satisfaction and impact of the bipolar disorder on life style. Bipolar Disord 2004; 6: 487–497
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Rosen AM, Caracci G, Shukla S. Persistent tardive dyskinesia in bipolar patients. Arch Gen Psychiatry 1986; 43: 342–346
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Sackeim HA, Schnur DB. Electroconvulsive therapy of acute manic episodes: a review of 50 years’ experience. Am J Psychiatry 1994; 151: 169–176
   PubMed Web of Science ®Google Scholar
• Müller AA, Stoll K-D. Carbamazepine and oxcarbamazepine in the treatment of manic syndromes: studies in Germany. Anticonvulsants in affective disorders, HM Emrich, T Okuma, AA Muller. Excerpta medica, Amsterdam 1984; 139–147
   Google Scholar
• Müller P, Heipertz R. Zur Behandlung manischer Psychosen mit Clozapin. Fortschr Neurol Psychiatr Grenzgeb 1977; 45: 420–424
   PubMedGoogle Scholar
• Müller-Oerlinghausen B, Retzow A, Henn F, Giedke H, Walden J. Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania. A prospective, randomized, double- blind, placebo-controlled multicenter study. J Clin Psychopharmacol 2000; 20: 195–203
   PubMed Web of Science ®Google Scholar
• Nasrallah, HA, Loebel, AD, Murray, SR, Batzar, E. 2004. Lipid profile pre- and post-treatment in ziprasidone clinical trials. Proc APA Annual Meeting NR 387.
   Google Scholar
• National Collaborating Centre for Mental Health. 2006. Bipolar disorder.The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. CG38: NICE Guideline. Electronic Citation National Institute for Health and Clinical Excellence.
   Google Scholar
• Neve ME, Huyser J, Eshuis JH, Storosum JG. Electroconvulsive therapy in therapy-resistant mania. A case study. Tijdschr Psychiatr 2007; 49: 851–854
   PubMedGoogle Scholar
• Niufan G, Tohen M, Qiuqing A, Fude Y, Pope E, McElroy H, et al. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial. J Affect Disord 2008; 105: 101–108
   PubMed Web of Science ®Google Scholar
• Nolen WA, Kupka RW, Schulte PFJ, Knoppert-van der Klein EAM, Honig A, Reichart CG, et al. Richtlijn bipolaire stoornissen2 ed. De Tijdstrom Uitgerverij BV, Utrecht 2008
   Google Scholar
• Okuma T, Kishimoto A, Inoue K, Matsumoto H, Ogura A. Anti-manic and prophylactic effects of carbamazepine (Tegretol) on manic depressive psychosis. A preliminary report. Folia Psychiatr Neurol Jpn 1973; 27: 283–297
   PubMedGoogle Scholar
• Okuma T, Inanaga K, Otsuki S, Sarai K, Takahashi R, Hazama H, et al. Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: a double-blind controlled study. Psychopharmacology 1979; 66: 211–217
   PubMed Web of Science ®Google Scholar
• Okuma T, Yamashita I, Takahashi R, Itoh H, Otsuki S, Watanabe S, et al. Comparison of the antimanic efficacy of carbamazepine and lithium carbonate by double-blind controlled study. Pharmacopsychiatry 1990; 23: 143–150
   PubMed Web of Science ®Google Scholar
• Pajonk FG, Schwertner AK, Seelig MA. Rapid dose titration of quetiapine for the treatment of acute schizophrenia and acute mania: a case series. J Psychopharmacol 2006; 20: 119–124
   PubMedGoogle Scholar
• Pande AC. Clonazepam treatment of atypical bipolar disorder. Psychosomatics 1988; 29: 333–335
   PubMedGoogle Scholar
• Pande AC, Crockatt JG, Janney CA, Werth JL, Tsaroucha G. Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group. Bipolar Disord 2000; 2: 249–255
   PubMed Web of Science ®Google Scholar
• Pappadopulos E, Vieta E, Mandel F. Day 4 partial resonse to ziprasidone predicts later treatment response in patients with bipolar disorder. Eur Neuropsychopharmacol 2008; 18(Suppl 4)443
   Google Scholar
• Peh AL, Tay LK. Demographical profile and clinical features of patients with bipolar disorder in an outpatient setting in Singapore. Singapore Med J 2008; 49: 380–383
   PubMedGoogle Scholar
• Perlis RH. Use of treatment guidelines in clinical decision making in bipolar disorder: a pilot survey of clinicians. Curr Med Res Opin 2007; 23: 467–475
   PubMed Web of Science ®Google Scholar
• Perlis RH, Perlis CS, Wu Y, Hwang C, Joseph M, Nierenberg AA. Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry. Am J Psychiatry 2005; 162: 1957–1960
   PubMed Web of Science ®Google Scholar
• Perlis RH, Baker RW, Zarate CA, Jr, Brown EB, Schuh LM, Jamal HH, et al. Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial. J Clin Psychiatry 2006a; 67: 1747–1753
   PubMed Web of Science ®Google Scholar
• Perlis RH, Welge JA, Vornik LA, Hirschfeld RM, Keck PE. Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials. J Clin Psychiatry 2006b; 67: 509–516
   PubMed Web of Science ®Google Scholar
• Placidi GF, Lenzi A, Lazzerini F, Cassano GB, Akiskal HS. The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3-year trial in 83 patients. J Clin Psychiatry 1986; 47: 490–494
   PubMed Web of Science ®Google Scholar
• Platman SR. A comparison of lithium carbonate and chlorpromazine in mania. Am J Psychiatry 1970; 127: 351–353
   PubMedGoogle Scholar
• Pope HG, McElroy SL, Keck PE, Hudson JI. Valproate in the treatment of acute mania. A placebo-controlled study. Arch Gen Psychiatry 1991; 48: 62–68
   PubMed Web of Science ®Google Scholar
• Popova E, Leighton C, Bernabarre A, Bernardo M, Vieta E. Oxcarbazepine in the treatment of bipolar and schizoaffective disorders. Expert Rev Neurother 2007; 7: 617–626
   PubMedGoogle Scholar
• Post RM, Uhde TW, Roy-Byrne PP, Joffe RT. Correlates of antimanic response to carbamazepine. Psychiatry Res 1987; 21: 71–83
   PubMed Web of Science ®Google Scholar
• Potkin SG, Keck PE, Jr, Segal S, Ice K, English P. Ziprasidone in acute bipolar mania: A 21-day randomized, double-blind, placebo-controlled replication trial. J Clin Psychopharmacol 2005a; 25: 301–310
   PubMed Web of Science ®Google Scholar
• Potkin SG, Keck PE, Jr, Segal S, Ice K, English P. Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial. J Clin Psychopharmacol 2005b; 25: 301–310
   PubMed Web of Science ®Google Scholar
• Prien RF, Caffey EM, Klett CJ. Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Arch Gen Psychiatry 1972; 26: 146–153
   PubMed Web of Science ®Google Scholar
• Rasgon NL, Altshuler LL, Fairbanks L, Elman S, Bitran J, Labarca R, et al. Reproductive function and risk for PCOS in women treated for bipolar disorder. Bipolar Disord 2005; 7: 246–259
   PubMed Web of Science ®Google Scholar
• Ray WA, Chung CP, Murray KT, Hall K, Stein CM. Atypical antipsychotic drugs and the risk of sudden cardiac death. New Engl J Med 2009; 360: 225–235
   PubMed Web of Science ®Google Scholar
• Regeer EJ, ten HM, Rosso ML, Hakkaart-van RL, Vollebergh W, Nolen WA. Prevalence of bipolar disorder in the general population: a Reappraisal Study of the Netherlands Mental Health Survey and Incidence Study. Acta Psychiatr Scand 2004; 110: 374–382
   PubMed Web of Science ®Google Scholar
• Remington G. Tardive dyskinesia: eliminated, forgotten, or overshadowed?. Curr Opin Psychiatry 2007; 20: 131–137
   PubMed Web of Science ®Google Scholar
• Rifkin A, Doddi S, Karajgi B, Borenstein M, Munne R. Dosage of haloperidol for mania. Br J Psychiatry 1994; 165: 113–116
   PubMed Web of Science ®Google Scholar
• Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Bipolar Disorder. 2004. Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder. Aust NZ J Psychiatry, 38:280–305.
   PubMedGoogle Scholar
• Runge C, Grunze H. Jährliche Krankheitskosten bipolarer Störungen in Deutschland. Nervenarzt 2004; 75: 896–903
   PubMed Web of Science ®Google Scholar
• Sachs G, Chengappa KN, Suppes T, Mullen JA, Brecher M, Devine NA, et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. Bipolar Disord 2004; 6: 213–223
   PubMed Web of Science ®Google Scholar
• Sachs G, Sanchez R, Marcus R, Stock E, McQuade R, Carson W, et al. Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study. J Psychopharmacol 2006; 20: 536–546
   PubMed Web of Science ®Google Scholar
• Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry 2002; 159: 1146–1154
   PubMed Web of Science ®Google Scholar
• Sanford M, Scott LJ. Intramuscular aripiprazole: a review of its use in the management of agitation in schizophrenia and bipolar I disorder. CNS Drugs 2008; 22: 335–352
   PubMed Web of Science ®Google Scholar
• Scherk H, Pajonk FG, Leucht S. Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials. Arch Gen Psychiatry 2007; 64: 442–455
   PubMed Web of Science ®Google Scholar
• Schneck CD. Bipolar disorder in neurologic illness. Curr Treat Options Neurol 2002; 4: 477–486
   PubMedGoogle Scholar
• Schneck CD, Miklowitz DJ, Miyahara S, Araga M, Wisniewski S, Gyulai L, et al. The prospective course of rapid-cycling bipolar disorder: findings from the STEP-BD. Am J Psychiatry 2008; 165: 370–377
   PubMed Web of Science ®Google Scholar
• Schou M, Juel-Nielsen N, Strömgren E, Voldby H. The treatment of manic psychoses by the administration of lithium salts. J Neurol Neurosurg Psychiatry 1954; 17: 250–260
   PubMed Web of Science ®Google Scholar
• Secunda SK, Swann A, Katz MM, Koslow SH, Croughan J, Chang S. Diagnosis and treatment of mixed mania. Am J Psychiatry 1987; 144: 96–98
   PubMed Web of Science ®Google Scholar
• Segal J, Berk M, Brook S. Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clin Neuropharmacol 1998; 21: 176–180
   PubMed Web of Science ®Google Scholar
• Shopsin B, Gershon S, Thompson H, Collins P. Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol. Arch Gen Psychiatry 1975; 32: 34–42
   PubMed Web of Science ®Google Scholar
• Sikdar S, Kulhara P, Avasthi A, Singh H. Combined chlorpromazine and electroconvulsive therapy in mania. Br J Psychiatry 1994; 164: 806–810
   PubMedGoogle Scholar
• Simpson SG, Jamison KR. The risk of suicide in patients with bipolar disorders. J Clin Psychiatry 60 Suppl 1999; 2: 53–56
   Google Scholar
• Small JG, Klapper MH, Kellams JJ, Miller MJ, Milstein V, Sharpley PH, et al. Electroconvulsive treatment compared with lithium in the management of manic states. Arch Gen Psychiatry 1988; 45: 727–732
   PubMed Web of Science ®Google Scholar
• Small JG, Klapper MH, Milstein V, Kellams JJ, Miller MJ, Marhenke JD, et al. Carbamazepine compared with lithium in the treatment of mania. Arch Gen Psychiatry 1991; 48: 915–921
   PubMed Web of Science ®Google Scholar
• Small JG, Klapper MH, Marhenke JD, Milstein V, Woodham GC, Kellams JJ. Lithium combined with carbamazepine or haloperidol in the treatment of mania. Psychopharmacol Bull 1995; 31: 265–272
   PubMed Web of Science ®Google Scholar
• Small JG, Klapper MH, Milstein V, Marhenke JD, Small IF. Comparison of therapeutic modalities for mania. Psychopharmacol Bull 1996; 32: 623–627
   PubMedGoogle Scholar
• Smith LA, Cornelius V, Warnock A, Tacchi MJ, Taylor D. Acute bipolar mania: a systematic review and meta-analysis of co-therapy vs. monotherapy. Acta Psychiatr Scand 2007a; 115: 12–20
   PubMed Web of Science ®Google Scholar
• Smith LA, Cornelius V, Warnock A, Tacchi MJ, Taylor D. Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials. Bipolar Disord 2007b; 9: 551–560
   PubMed Web of Science ®Google Scholar
• Smulevich AB, Khanna S, Eerdekens M, Karcher K, Kramer M, Grossman F. Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol. Eur Neuropsychopharmacol 2005; 15: 75–84
   PubMed Web of Science ®Google Scholar
• Soares JC. Valproate treatment and the risk of hyperandrogenism and polycystic ovaries. Bipolar Disord 2000; 2: 37–41
   PubMedGoogle Scholar
• Soares MB, Moreno RA, Moreno DH. Electroconvulsive therapy in treatment-resistant mania: case reports. Rev Hosp Clin Fac Med Sao Paulo 2002; 57: 31–38
   PubMedGoogle Scholar
• Spina E, Pisani F, Perucca E. Clinically significant pharmacokinetic drug interactions with carbamazepine. An update. Clin Pharmacokinet 1996; 31: 198–214
   PubMed Web of Science ®Google Scholar
• Spring G, Schweid D, Gray C, Steinberg J, Horwitz M. A double-blind comparison of lithium and chlorpromazine in the treatment of manic states. Am J Psychiatry 1970; 126: 1306–1310
   PubMed Web of Science ®Google Scholar
• Stoll KD, Bisson HE, Fischer E, Gammel G, Goncalves N, Kröber HL, . Carbamazepine versus haloperidol in manic syndromes. Biological psychiatry, C Shagass, RC Josiassen, WH Bridger, KJ Weiss, D Stoff, GM Simpson, et al. Elsevier, New York 1986; 332–334
   Google Scholar
• Storosum JG, Wohlfarth T, Schene A, Elferink A, van Zwieten BJ, van den BW. Magnitude of effect of lithium in short-term efficacy studies of moderate to severe manic episode. Bipolar Disord 2007; 9: 793–798
   PubMedGoogle Scholar
• Suppes T, McElroy SL, Gilbert J, Dessain EC, Cole J. Clozapine in the treatment of dysphoric mania. Biol Psychiatry 1992; 32: 270–280
   PubMed Web of Science ®Google Scholar
• Suppes T, Chisholm KA, Dhavale D, Frye MA, Altshuler LL, McElroy SL, et al. Tiagabine in treatment refractory bipolar disorder: a clinical case series. Bipolar Disord 2002; 4: 283–289
   PubMed Web of Science ®Google Scholar
• Suppes T, Mintz J, McElroy SL, Altshuler LL, Kupka RW, Frye MA, et al. Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network: a sex-specific phenomenon. Arch Gen Psychiatry 2005; 62: 1089–1096
   PubMed Web of Science ®Google Scholar
• Swann AC, Bowden CL, Morris D, Calabrese JR, Petty F, Small J, et al. Depression during mania. Treatment response to lithium or divalproex. Arch Gen Psychiatry 1997; 54: 37–42
   PubMed Web of Science ®Google Scholar
• Swann AC, Bowden CL, Calabrese J, Dilsaver SC, Morris DD. Pattern of response to divalproex, lithium, or placebo in four naturalistic subtypes of mania. Neuropsychopharmacology 2002; 26: 530–536
   PubMed Web of Science ®Google Scholar
• Takahashi R, Sakuma A, Itoh K, Itoh H, Kurihara M. Comparison of efficacy of lithium carbonate and chlorpromazine in mania. Report of collaborative study group on treatment of mania in Japan. Arch Gen Psychiatry 1975; 32: 1310–1318
   PubMedGoogle Scholar
• Thomas J, Reddy B. The treatment of mania. A retrospective evaluation of the effects of ECT, chlorpromazine, and lithium. J Affect Disord 1982; 4: 85–92
   PubMed Web of Science ®Google Scholar
• Thomas, P, Vieta, E, for the SOLMANIA study group. 2008. Amisulpride plus valproate vs. haloperidol plus valproate in the treatment of acute mania of bipolar I patients: a multicenter, open-label, randomized, comparative trial. Neuropsychiatr Dis Treat, 4:1–12.
   PubMedGoogle Scholar
• Tohen M. Clinical trials in bipolar mania: implications in study design and drug development. Arch Gen Psychiatry 2008; 65: 252–253
   PubMedGoogle Scholar
• Tohen M, Sanger TM, McElroy SL, Tollefson GD, Chengappa KN, Daniel DG, et al. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am J Psychiatry 1999; 156: 702–709
   PubMed Web of Science ®Google Scholar
• Tohen M, Jacobs TG, Grundy SL, McElroy SL, Banov MC, Janicak PG, et al. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study Group. Arch Gen Psychiatry 2000; 57: 841–849
   PubMed Web of Science ®Google Scholar
• Tohen M, Zhang F, Taylor CC, Burns P, Zarate C, Sanger T, et al. A meta-analysis of the use of typical antipsychotic agents in bipolar disorder. J Affect Disord 2001; 65: 85–93
   PubMedGoogle Scholar
• Tohen M, Chengappa KN, Suppes T, Zarate CA, Calabrese JR, Bowden CL, et al. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry 2002; 59: 62–69
   PubMed Web of Science ®Google Scholar
• Tohen M, Goldberg JF, Gonzalez-Pinto Arrillaga AM, Azorin JM, Vieta E, Hardy-Bayle MC, et al. A 12-week, double-blind comparison of olanzapine vs. haloperidol in the treatment of acute mania. Arch Gen Psychiatry 2003a; 60: 1218–1226
   PubMed Web of Science ®Google Scholar
• Tohen M, Ketter TA, Zarate CA, Suppes T, Frye M, Altshuler L, et al. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am J Psychiatry 2003b; 160: 1263–1271
   PubMed Web of Science ®Google Scholar
• Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 2003c; 60: 1079–1088
   PubMed Web of Science ®Google Scholar
• Tohen M, Zarate CA, Hennen J, Khalsa HM, Strakowski SM, Gebre-Medhin P, et al. The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. Am J Psychiatry 2003d; 160: 2099–2107
   PubMed Web of Science ®Google Scholar
• Tohen M, Bowden CL, Calabrese JR, Lin D, Forrester TD, Sachs GS, et al. Influence of sub-syndromal symptoms after remission from manic or mixed episodes. Br J Psychiatry 2006a; 189: 515–519
   PubMed Web of Science ®Google Scholar
• Tohen M, Calabrese JR, Sachs GS, Banov MD, Detke HC, Risser R, et al. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. Am J Psychiatry 2006b; 163: 247–256
   PubMed Web of Science ®Google Scholar
• Tohen M, Kryzhanovskaya L, Carlson G, DelBello M, Wozniak J, Kowatch R, et al. Olanzapine versus placebo in the treatment of adolescents with bipolar mania. Am J Psychiatry 2007; 164: 1547–1556
   PubMed Web of Science ®Google Scholar
• Tohen M, Bowden CL, Smulevich AB, Bergstrom R, Quinlan T, Osuntokun O, et al. Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes. Br J Psychiatry 2008; 192: 135–143
   PubMed Web of Science ®Google Scholar
• Tohen, M, Frank, E, Bowden, CL, Colom, F, Ghaemi, NS, Yatham, LN, , et al. 2009a. The International Society of Bipolar Disorders (ISBD) Task Force on the Nomenclature of Course and Outcome in Bipolar Disorders. Bipolar Disord, in press.
   Google Scholar
• Tohen, M, Vieta, E, Goodwin, GM, Sun, B, Amsterdam, JD, Banov, M, , et al. 2009b. Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: A randomized, 12-week, double-blind study. J Clin Psychiatry, in press.
   Google Scholar
• van Winkel R, De Hert M, Wampers M, Van Eyck D, Hanssens L, Scheen A, et al. Major changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disorder. J Clin Psychiatry 2008; 69: 472–479
   PubMed Web of Science ®Google Scholar
• Vasudev K, Goswami U, Kohli K. Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder. Psychopharmacology (Berlin) 2000; 150: 15–23
   PubMed Web of Science ®Google Scholar
• Vieta E. Divalproex versus olanzapine in mania. J Clin Psychiatry 2003; 64: 1266–1267
   PubMedGoogle Scholar
• Vieta E. The treatment of mixed states and the risk of switching to depression. Eur Psychiatry 2005; 20: 96–100
   PubMedGoogle Scholar
• Vieta E, Gasto C, Colom F, Reinares M, Martinez-Aran A, Benabarre A, et al. Role of risperidone in bipolar II: an open 6-month study. J Affect Disord 2001; 67: 213–219
   PubMed Web of Science ®Google Scholar
• Vieta E, Calabrese JR, Hennen J, Colom F, Martinez-Aran A, Sanchez-Moreno J, et al. Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled data. J Clin Psychiatry 2004; 65: 1420–1428
   PubMed Web of Science ®Google Scholar
• Vieta E, Bourin M, Sanchez R, Marcus R, Stock E, McQuade R, et al. Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial 4829. Br J Psychiatry 2005a; 187: 235–242
   PubMed Web of Science ®Google Scholar
• Vieta E, Ros S, Goikolea JM, Benabarre A, Popova E, Comes M, et al. An open-label study of amisulpride in the treatment of mania. J Clin Psychiatry 2005b; 66: 575–578
   PubMedGoogle Scholar
• Vieta E, Panicali F, Goetz I, Reed C, Comes M, Tohen M. Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study. J Affect Disord 2008b; 106: 63–72
   PubMed Web of Science ®Google Scholar
• Vieta, E, Berwaerts, J, Nuamah, I, Lim, P, Yuen, E, Palumbo, J, , et al. 2009a. Randomised, placebo, active-controlled study of paliperidone extended-release (ER) for acute manic and mixed episodes in bipolar I disorder. Eur Neuropsychopharmacol, in press.
   PubMedGoogle Scholar
• Vieta, E, Ramey, TS, Keller, D, English, PA, Loebel, AD, Miceli, JJ. 2009b. Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study. J Psychopharmacol, in press.
   Google Scholar
• Vieta, E, Tjoen, C, McQuade, RD, Carson, WH, Jr, Marcus, RN, Sanchez, R, , et al. 2009c. Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: A placebo-controlled study. Am J Psychiatry, in press.
   PubMedGoogle Scholar
• Viguera AC, Koukopoulos A, Muzina DJ, Baldessarini RJ. Teratogenicity and anticonvulsants: lessons from neurology to psychiatry. J Clin Psychiatry 2007; 68(Suppl 9)29–33
   PubMed Web of Science ®Google Scholar
• Volpe FM, Tavares A. Manic patients receiving ECT in a Brazilian sample. J Affect Disord 2004; 79: 201–208
   PubMedGoogle Scholar
• Walton SA, Berk M, Brook S. Superiority of lithium over verapamil in mania: A randomized, controlled, single-blind trial. J Clin Psychiatry 1996; 57: 543–546
   PubMed Web of Science ®Google Scholar
• Warrington L, Lombardo I, Loebel A, Ice K. Ziprasidone for the treatment of acute manic or mixed episodes associated with bipolar disorder. CNS Drugs 2007; 21: 835–849
   PubMedGoogle Scholar
• Weisler R, Warrington L, Dunn J. Adjunctive ziprasidone in bipolar mania: Short- and long-term data. Biol Psychiatry 2004a; 55(Suppl 1)148
   PubMedGoogle Scholar
• Weisler RH, Kalali AH, Ketter TA. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. J Clin Psychiatry 2004b; 65: 478–484
   PubMed Web of Science ®Google Scholar
• Weisler RH, Keck PEJR, Swann AC, Cutler AJ, Ketter TA, Kalali AH. Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2005; 66: 323–330
   PubMed Web of Science ®Google Scholar
• Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, et al. Cross-national epidemiology of major depression and bipolar disorder. J Am Med Assoc 1996; 276: 293–299
   PubMed Web of Science ®Google Scholar
• Whitlock FA, Evans LE. Drugs and depression. Drugs 1978; 15: 53–71
   PubMedGoogle Scholar
• Wolfsperger M, Greil W, Rossler W, Grohmann R. Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004. J Affect Disord 2007; 99: 9–17
   PubMedGoogle Scholar
• Woods SW. The economic burden of bipolar disease. J Clin Psychiatry 2000; 61(Supp 13)38–41
   PubMed Web of Science ®Google Scholar
• World Health Organization. 1992. The ICD-10 Classification of mental and behavioural disorders. Clinical descriptions and diagnostic guidelines. Geneva: WHO.
   Google Scholar
• Yatham LN, Grossman F, Augustyns I, Vieta E, Ravindran A. Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial. Br J Psychiatry 2003; 182: 141–147
   PubMed Web of Science ®Google Scholar
• Yatham LN, Paulsson B, Mullen J, Vagero AM. Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania. J Clin Psychopharmacol 2004; 24: 599–606
   PubMed Web of Science ®Google Scholar
• Yatham LN, Kennedy SH, O'Donovan C, Parikh SV, Macqueen G, McIntyre RS, Sharma V, Beaulieu S. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. Bipolar Disord 2006; 8: 721–739
   PubMed Web of Science ®Google Scholar
• Yatham LN, Vieta E, Young AH, Möller HJ, Paulsson B, Vagero M. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania. Int Clin Psychopharmacol 2007; 22: 212–220
   PubMed Web of Science ®Google Scholar
• Yildiz A, Guleryuz S, Ankerst DP, Ongur D, Renshaw PF. Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen. Arch Gen Psychiatry 2008; 65: 255–263
   PubMed Web of Science ®Google Scholar
• Young AH, Oren DA, Lowy A, McQuade RD, Marcus RN, Carson WH, et al. Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study. Br J Psychiatry 2009; 194: 40–48
   PubMed Web of Science ®Google Scholar
• Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429–435
   PubMed Web of Science ®Google Scholar
• Zajecka JM, Weisler R, Sachs G, Swann AC, Wozniak P, Sommerville KW. A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder. J Clin Psychiatry 2002; 63: 1148–1155
   PubMed Web of Science ®Google Scholar
• Zarate CA, Tohen M. Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients. Am J Psychiatry 2004; 161: 169–171
   PubMed Web of Science ®Google Scholar
• Zarate CA, Jr, Singh JB, Carlson PJ, Quiroz J, Jolkovsky L, Luckenbaugh DA, et al. Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study. Bipolar Disord 2007; 9: 561–570
   PubMed Web of Science ®Google Scholar
• Zarin, D, Pincus, HA, McIntyre, JS. 2002. APA Practice Guideline For The Treatment Of Patients With Bipolar Disorder. Electronic Citation http://www.psych.org/clin_res/pg_bipolar.cfm.
   Google Scholar
• Zimmerman M, Ruggero CJ, Chelminski I, Young D. Is bipolar disorder overdiagnosed?. J Clin Psychiatry 2008; 69: 935–940
   PubMed Web of Science ®Google Scholar